34.53
Precedente Chiudi:
$35.59
Aprire:
$35.98
Volume 24 ore:
61,268
Relative Volume:
1.52
Capitalizzazione di mercato:
$249.50M
Reddito:
-
Utile/perdita netta:
$-4.98M
Rapporto P/E:
-26.20
EPS:
-1.3177
Flusso di cassa netto:
$-3.85M
1 W Prestazione:
+3.30%
1M Prestazione:
+27.64%
6M Prestazione:
-20.64%
1 anno Prestazione:
+3,130%
Bright Minds Biosciences Inc Stock (DRUG) Company Profile
Nome
Bright Minds Biosciences Inc
Settore
Industria
Telefono
-
Indirizzo
-
Confronta DRUG con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
DRUG
Bright Minds Biosciences Inc
|
35.42 | 250.82M | 0 | -4.98M | -3.85M | -1.3177 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
376.54 | 96.11B | 11.42B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
560.57 | 60.40B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
427.58 | 54.91B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
668.51 | 41.30B | 3.05B | 1.28B | -614.78M | 19.58 |
![]()
ONC
Beone Medicines Ltd Adr
|
294.62 | 33.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Bright Minds Biosciences Inc Stock (DRUG) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-05-13 | Iniziato | TD Cowen | Buy |
2025-05-07 | Iniziato | Chardan Capital Markets | Buy |
2025-01-23 | Iniziato | Piper Sandler | Overweight |
2025-01-10 | Iniziato | Cantor Fitzgerald | Overweight |
2025-01-10 | Iniziato | H.C. Wainwright | Buy |
2024-11-26 | Iniziato | Robert W. Baird | Outperform |
Mostra tutto
Bright Minds Biosciences Inc Borsa (DRUG) Ultime notizie
Bright Minds Biosciences Inc. stock outlook for YEARMomentum Screener with Buy and Sell Areas - Newser
How to track smart money flows in Bright Minds Biosciences Inc.Weekly Outlook for Short Term Investors - Newser
Bright Minds Biosciences Inc. Earnings Report Breakdown: What Investors Should KnowReal-Time Investment Signal Forecast with AI - Newser
Chart based exit strategy for Bright Minds Biosciences Inc.Market Correction Proof Stock Screening Analysis - Newser
How Bright Minds Biosciences Inc. stock performs during market volatilityMomentum Prediction Based on AI Backtesting - Newser
Is LIMNW showing signs of accumulationAI Risk Optimized Trade Forecast Planner - Newser
Bright Minds Biosciences Inc. Stock Chart Analysis: Bullish or Bearish Pattern FormingFree Consistent Profit Pattern Recognition Tools - Newser
Sentiment analysis tools applied to Bright Minds Biosciences Inc.Free Safe Entry Stock Watch Suggestions - Newser
Will Bright Minds Biosciences Inc. Recover After Recent DeclineInvestment Playbook for Growing Markets Shared - metal.it
Earnings visualization tools for Bright Minds Biosciences Inc.Trading Volume Spike and Reversal Analysis - Newser
What makes Bright Minds Biosciences Inc. stock price move sharplyLong-Term Stock Growth Forecast Insights - Newser
Should I hold or sell Bright Minds Biosciences Inc. stock in 2025Unlock daily market insights for better trades - Jammu Links News
What are the technical indicators suggesting about Bright Minds Biosciences Inc.Invest smarter with data-backed trading alerts - Jammu Links News
What institutional investors are buying Bright Minds Biosciences Inc. stockAchieve rapid financial growth with expert picks - Jammu Links News
What analysts say about Bright Minds Biosciences Inc. stockInvest confidently with actionable market data - Jammu Links News
How many analysts rate Bright Minds Biosciences Inc. as a “Buy”Free Stock Chart Pattern Guide - Jammu Links News
When is Bright Minds Biosciences Inc. stock expected to show significant growthHigh-octane investment opportunities await - Jammu Links News
How strong is Bright Minds Biosciences Inc. company’s balance sheetAchieve exceptional returns with expert guidance - Jammu Links News
What catalysts could drive Bright Minds Biosciences Inc. stock higher in 2025Discover market opportunities others miss - Jammu Links News
Why Bright Minds Biosciences Inc. stock attracts strong analyst attentionVolume Based Entry Signal Summary - beatles.ru
Can Bright Minds Biosciences Inc. stock recover from recent declineFree Low Risk Buy Zone Opportunity Watch - Newser
Why is Bright Minds Biosciences Inc. stock attracting strong analyst attentionRealize consistent double-digit growth - Jammu Links News
What are analysts’ price targets for Bright Minds Biosciences Inc. in the next 12 monthsFind the best stocks for sustainable growth - Jammu Links News
Technical signs of recovery in Bright Minds Biosciences Inc.Free Investment Plan With Growth Optimization - Newser
What are Bright Minds Biosciences Inc. company’s key revenue driversReal Time Alerts For Fast Growth - Jammu Links News
Full technical analysis of Bright Minds Biosciences Inc. stockShort Term Momentum Based Trading Strategy - Newser
What is Bright Minds Biosciences Inc. company’s growth strategyExpert Picks Insights For Fast Growth - jammulinksnews.com
New Product Launches: Will They Boost Bright Minds Biosciences Inc. Stock in 2025Controlled Entry Strategy With Safety Analytics - Newser
Published on: 2025-07-30 02:55:13 - metal.it
Short Interest Drops in Bright Minds Biosciences Inc. After RallyROI Driven Equity Selection With Safety Emphasized - beatles.ru
Bright Minds Biosciences Inc. Sees Relief Buying After Extended DropPattern Alert With ROI Driven Strategy Shared - metal.it
Published on: 2025-07-29 04:17:58 - Newser
Does Bright Minds Biosciences Inc. stock pay reliable dividendsFree Short Term Buy List With Stop Protection - Newser
What are the latest earnings results for Bright Minds Biosciences Inc.Invest in stocks with long-term growth potential - jammulinksnews.com
What is the risk reward ratio of investing in Bright Minds Biosciences Inc. stockDiscover high-growth stocks for your portfolio - jammulinksnews.com
Bright Minds Biosciences Inc Azioni (DRUG) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Bright Minds Biosciences Inc Azioni (DRUG) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
Cormorant Asset Management, LP | 10% Owner |
Oct 15 '24 |
Buy |
5.53 |
372,591 |
2,061,574 |
825,000 |
Cormorant Asset Management, LP | 10% Owner |
Oct 16 '24 |
Buy |
23.46 |
50,000 |
1,172,813 |
875,000 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):